Your browser doesn't support javascript.
loading
Evaluation of Ivermectin as a Potential Treatment for Mild to Moderate COVID-19: A Double-Blind Randomized Placebo Controlled Trial in Eastern India.
Roy, Ranjini; Pattadar, Chandrima; Raj, Rishav; Agarwal, Neeraj; Biswas, Bijit; Manjhi, Pramod Kumar; Rai, Deependra Kumar; Kumar, Anjani; Sarfaraz, Asim.
Affiliation
  • Ravikirti; Additional Professor and Head, Department of General Medicine, All India Institute of Medical Sciences, Patna, Bihar, India.
  • Roy R; Postgraduate Trainee, Department of General Medicine, All India Institute of Medical Sciences, Patna, Bihar, India.
  • Pattadar C; Postgraduate Trainee, Department of General Medicine, All India Institute of Medical Sciences, Patna, Bihar, India.
  • Raj R; Postgraduate Trainee, Department of General Medicine, All India Institute of Medical Sciences, Patna, Bihar, India.
  • Agarwal N; Professor and Head, Department of Community and Family Medicine, All India Institute of Medical Sciences, Bibinagar, Telangana, India.
  • Biswas B; Senior Resident, Department of Community and Family Medicine, All India Institute of Medical Sciences, Patna, Bihar, India.
  • Manjhi PK; Assistant Professor and Head, Department of Pharmacology, All India Institute of Medical Sciences, Patna, Bihar, India.
  • Rai DK; Additional Professor and Head, Department of Pulmonary Medicine, All India Institute of Medical Sciences, Patna, Bihar, India.
  • Shyama; Assistant Professor, Department of General Medicine, All India Institute of Medical Sciences, Patna, Bihar, India.
  • Kumar A; Assistant Professor, Department of General Medicine, All India Institute of Medical Sciences, Patna, Bihar, India.
  • Sarfaraz A; Assistant Professor, Department of Microbiology, All India Institute of Medical Sciences, Patna, Bihar, India.
J Pharm Pharm Sci ; 24: 343-350, 2021.
Article in En | MEDLINE | ID: mdl-34265236
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ivermectin / SARS-CoV-2 / COVID-19 Drug Treatment Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: J Pharm Pharm Sci Journal subject: FARMACIA / FARMACOLOGIA Year: 2021 Document type: Article Affiliation country: India Country of publication: Suiza
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ivermectin / SARS-CoV-2 / COVID-19 Drug Treatment Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: J Pharm Pharm Sci Journal subject: FARMACIA / FARMACOLOGIA Year: 2021 Document type: Article Affiliation country: India Country of publication: Suiza